← Back to Search

Behavioral Intervention

Improving Quality of Life in Men and Women With Overweight or Obesity

N/A
Waitlist Available
Research Sponsored by Noom Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group

Summary

This trial is testing the Noom Healthy Weight Program, an online tool that helps people lose weight by changing their habits. The study focuses on people who want to lose weight and aims to see if the program improves their quality of life. The program works by providing daily tasks, educational content, and support to help users make healthier choices. Noom is a smartphone-based behavioral weight loss program that has been used in various studies to test its effectiveness in weight reduction.

Eligible Conditions
  • Obesity
  • Quality of Life
  • Health Behaviors

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 4 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
In app engagement measures
Stress
Weight
Secondary study objectives
Appetite and food craving
Depression and anxiety
Perceived physical and mental health over time
+5 more
Other study objectives
COVID status

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Noom Healthy WeightExperimental Treatment1 Intervention
Group II: Wait ListActive Control1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Noom Healthy Weight
2021
N/A
~410

Find a Location

Who is running the clinical trial?

Noom Inc.Lead Sponsor
16 Previous Clinical Trials
2,470 Total Patients Enrolled
9 Trials studying Obesity
1,838 Patients Enrolled for Obesity
~79 spots leftby Dec 2025